The BioSpherix System provides an operational advantage through reduced processing times and less time spent gowning-up.

We provide a constant physiologic environment with the Xvivo, so we’re hitting the cells with only defined components and we know exactly what we’re changing. We put the cell at the center and it works.

If you could look into the future, this would be the future of organ transplantation…This is much more elegant and much safer. This is like a new chapter in medicine.

The Xvivo barrier isolator system for cells was the answer to our prayers. Their technology allowed us to safely build a new trachea for our patient and virtually eliminated the risk of contamination

The enhanced flexibility of the system allows me to have reduced staffing and staff flexibility. Technicians efficiently move back and forth within reduced classification suites. In addition, the enhanced reagent flow in and out of the operating space is a plus for our multiple trials. Another advantage of the technology is our ability to separate our processes – if we make changes to one unit the rest of them are unchanged.

Bristol-Myers Squibb selected the BioSpherix Isolator for the soft, clear design of the isolator fact and its tactile gloves. We also especially liked the versatility provided by the modular units that made customizing modules of different configurations very easy. At FAT, the team was impressed with the ability of the Isolator to rapidly clear particle counts.

“The other big advantage is between BioSpherix isolators vs. traditional stainless steel isolators, is that I can rearrange these modules however I want. That is a huge advantage when developing a strategy for cell therapy replacement. There’s a lot we don’t know, so modularity is key.”

Thank you, BioSpherix, for the good equipment you have provided us. It gave us the necessary tools to study MSC in their adequate environments (Normoxia, Hypoxia and Anoxia). Well done!